Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)

NCT03918148 · clinicaltrials.gov ↗

COMPLETED

Status

1150

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: SGLT-2i
DRUG: DPP-4i

Sponsor

University of Campania Luigi Vanvitelli